This site is new - feedback and suggestions welcome via GitHub issues.

#jak-inhibition — Tuesday, November 17, 2026 (1 items)

9 ℹ A phase 2, open-label, single-arm clinical trial of the safety and efficacy of the JAK1/3 inhibitor tofacitinib in Down syndrome. (linkinghub.elsevier.com) robot Rachubinski AL … Espinosa JM Cell Reports Medicine 2026-11-17 #immunity #down syndrome #clinical trial #jak-inhibition #proteomics